share_log

Merck & Co | 144: Notice of proposed sale of securities pursuant to Rule 144

默沙东 | 144:拟议出售证券

美股SEC公告 ·  02/09 16:12
Moomoo AI 已提取核心信息
Merck & Co. officer Dean Li is set to sell 14,702 shares of the company's common stock on February 9, 2024, according to a recent filing. The shares, valued at approximately $1.85 million, were acquired on the same date through the exercise of options under a registered plan. The transaction will be executed by cash payment. No prior sales of securities have been reported by Li in the past three months.
Merck & Co. officer Dean Li is set to sell 14,702 shares of the company's common stock on February 9, 2024, according to a recent filing. The shares, valued at approximately $1.85 million, were acquired on the same date through the exercise of options under a registered plan. The transaction will be executed by cash payment. No prior sales of securities have been reported by Li in the past three months.
根据最近的一份文件,默沙东公司高管李迪安定于2024年2月9日出售公司14,702股普通股。这些股票价值约185万美元,于同日通过行使注册计划下的期权收购。该交易将通过现金付款执行。在过去的三个月中,李没有报告过证券的先前销售情况。
根据最近的一份文件,默沙东公司高管李迪安定于2024年2月9日出售公司14,702股普通股。这些股票价值约185万美元,于同日通过行使注册计划下的期权收购。该交易将通过现金付款执行。在过去的三个月中,李没有报告过证券的先前销售情况。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息